Smartleaf Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81.6K Sell
1,314
-85
-6% -$5.99K ﹤0.01% 1220
2025
Q4
$94.7K Buy
1,399
+251
+22% +$16.9K ﹤0.01% 1216
2025
Q3
$84.1K Buy
1,148
+777
+209% +$51.6K 0.01% 1160
2025
Q2
$19.4K Sell
371
-528
-59% -$30K ﹤0.01% 1569
2025
Q1
$57.4K Buy
899
+28
+3% +$1.63K 0.01% 1078
2024
Q4
$41.8K Buy
871
+197
+29% +$10.1K ﹤0.01% 1256
2024
Q3
$38.4K Buy
674
+146
+28% +$8.37K ﹤0.01% 1014
2024
Q2
$27.3K Buy
528
+512
+3,200% +$22.5K ﹤0.01% 920
2024
Q1
$651 Buy
16
+10
+167% +$375 ﹤0.01% 1702
2023
Q4
$0 Buy
+6
New +$226 ﹤0.01% 1172

Other funds holding HALO

Smartleaf Asset Management's HALO Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Halozyme (HALO) stake by 6.1% in Q1 2026, selling an estimated $5.99K and leaving 1,314 shares worth $81.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

Smartleaf Asset Management first reported a position in HALO in Q4 2023 and has held it in 10 quarters since. The position peaked at $94.7K in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Smartleaf Asset Management held 1,314 shares of Halozyme worth $81.6K as of Q1 2026.
  • Smartleaf Asset Management sold 85 Halozyme shares in Q1 2026, an estimated $5.99K.
  • Halozyme made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1220 holding.
  • Smartleaf Asset Management first reported a position in Halozyme in Q4 2023 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Halozyme position peaked at $94.7K in Q4 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.